These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38902983)

  • 1. Influences on COVID-19 booster uptake among adults intending to receive a booster: a qualitative study.
    Moore R; Purvis RS; Willis DE; Li J; Selig JP; Ross J; McElfish PA
    Health Promot Int; 2024 Jun; 39(3):. PubMed ID: 38902983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose.
    Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM
    J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 booster uptake among US adults: Assessing the impact of vaccine attributes, incentives, and context in a choice-based experiment.
    Raman S; Kriner D; Ziebarth N; Simon K; Kreps S
    Soc Sci Med; 2022 Oct; 310():115277. PubMed ID: 36001917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.
    Lee IT; Cosgrove CA; Moore P; Bethune C; Nally R; Bula M; Kalra PA; Clark R; Dargan PI; Boffito M; Sheridan R; Moran E; Darton TC; Burns F; Saralaya D; Duncan CJA; Lillie PJ; San Francisco Ramos A; Galiza EP; Heath PT; Girard B; Parker C; Rust D; Mehta S; de Windt E; Sutherland A; Tomassini JE; Dutko FJ; Chalkias S; Deng W; Chen X; Feng J; Tracy L; Zhou H; Miller JM; Das R;
    Lancet Infect Dis; 2023 Sep; 23(9):1007-1019. PubMed ID: 37348519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022.
    Lu PJ; Zhou T; Santibanez TA; Jain A; Black CL; Srivastav A; Hung MC; Kriss JL; Schorpp S; Yankey D; Sterrett N; Fast HE; Razzaghi H; Elam-Evans LD; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):190-198. PubMed ID: 36795677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the intention to receive the COVID-19 booster vaccine based on the health belief model.
    Ventonen M; Douglas-Smith N; Hatin B
    Acta Psychol (Amst); 2024 Jun; 246():104254. PubMed ID: 38631152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    Khezri M; McKnight C; Weng CA; Kimball S; Des Jarlais D
    PLoS One; 2024; 19(5):e0303394. PubMed ID: 38743729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial.
    Dixit A; Bennett R; Ali K; Griffin C; Clifford RA; Turner M; Poston R; Hautzinger K; Yeakey A; Girard B; Zhou W; Deng W; Zhou H; Schnyder Ghamloush S; Kuter BJ; Slobod K; Miller JM; Priddy F; Das R;
    Lancet Infect Dis; 2024 Jul; 24(7):687-697. PubMed ID: 38518789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses.
    Parsons Leigh J; FitzGerald EA; Moss SJ; Cherak MS; Brundin-Mather R; Dodds A; Stelfox HT; Dubé È; Fiest KM; Halperin DM; Ahmed SB; MacDonald SE; Straus SE; Manca T; Ng Kamstra J; Soo A; Longmore S; Kupsch S; Sept B; Halperin SA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2316417. PubMed ID: 38390696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to the future uptake of regular COVID-19 booster vaccinations among young adults in the UK.
    Williams L; Gallant A; Brown L; Corrigan K; Crowe K; Hendry E
    Hum Vaccin Immunother; 2022 Nov; 18(6):2129238. PubMed ID: 36194693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota.
    Ricke IJ; Spaulding AB; Rajtar NN; Benton EM; Anderson IG; Lundberg L; Mussiel A; Nguyen RHN
    Vaccine; 2024 May; 42(15):3499-3504. PubMed ID: 38641495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare workers' attitudes toward and factors influencing their acceptance of an annual COVID-19 booster vaccine: a cross-sectional study in Palestine.
    Maraqa B; Nazzal Z; Baroud H; Douden M; El Hamshary Y; Jalamneh T
    BMC Health Serv Res; 2024 May; 24(1):624. PubMed ID: 38745215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to COVID-19 vaccination by socio-economic status in older Singaporean adults: a population-based cohort study.
    Wee LE; Yap AJW; Dickens B; Tan S; Ong B; Lye DC; Tan KB
    Public Health; 2024 Aug; 233():38-44. PubMed ID: 38850601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose.
    Roozen GVT; Prins MLM; Prins C; Janse JJ; de Gruyter HLM; Pothast CR; Huisman W; Koopman JPR; Lamers OAC; Kuijer M; Myeni SK; van Binnendijk RS; Hartog GD; Heemskerk MHM; Jochems SP; Feltkamp MCW; Kikkert M; Rosendaal FR; Roestenberg M; Visser LG; Roukens AHE
    Clin Microbiol Infect; 2024 Jul; 30(7):930-936. PubMed ID: 38552793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
    Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
    Agrawal U; Bedston S; McCowan C; Oke J; Patterson L; Robertson C; Akbari A; Azcoaga-Lorenzo A; Bradley DT; Fagbamigbe AF; Grange Z; Hall ECR; Joy M; Katikireddi SV; Kerr S; Ritchie L; Murphy S; Owen RK; Rudan I; Shah SA; Simpson CR; Torabi F; Tsang RSM; de Lusignan S; Lyons RA; O'Reilly D; Sheikh A
    Lancet; 2022 Oct; 400(10360):1305-1320. PubMed ID: 36244382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.